Viridian Therapeutics, Inc.\DE short interest in 2019
In 2019, Viridian Therapeutics, Inc.\DE's disclosed short interest ran from 2.72% of shares outstanding on 15 Oct 2019 to 1.80% on 31 Dec 2019, a change of -0.92 percentage points. The year's high was 2.72% on 15 Oct 2019 and its low 1.80% on 31 Dec 2019, averaging 2.22% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.61 days on 15 Oct 2019. Full history: Viridian Therapeutics, Inc.\DE.
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2019 in figures
- Start of year
- 2.72% (15 Oct 2019)
- End of year
- 1.80% (31 Dec 2019)
- Change
- -0.92 pp
- High
- 2.72% (15 Oct 2019)
- Low
- 1.80% (31 Dec 2019)
- Average
- 2.22%
- Highest days to cover
- 7.61 (15 Oct 2019)
- SEC filings marked
- 8
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Oct 2019 | 2.72% | 7.61 | results (8-K), 10-K filed, results (8-K), 10-Q filed, results (8-K), 10-Q filed |
| 31 Oct 2019 | 2.61% | 2.95 | |
| 15 Nov 2019 | 2.15% | 4.53 | results (8-K), 10-Q filed |
| 29 Nov 2019 | 2.04% | 1.94 | |
| 13 Dec 2019 | 2.02% | 1.52 | |
| 31 Dec 2019 | 1.80% | 1.16 |
See also: Viridian Therapeutics, Inc.\DE's full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.